Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Expert Rev Hematol. 2020 Jun 12;13(7):719–729. doi: 10.1080/17474086.2020.1772745

Table 3.

Summary of recommendations for obstetrical care of women with factor XI deficiency.

Multidisciplinary Care Team
  • Preconception or early pregnancy consultation with hematology

  • Preconception or early pregnancy consultation with maternal-fetal medicine/perinatology

  • Consideration for preconception or early pregnancy consultation with genetic counseling

  • Routine prenatal care with obstetrician and/or midwife

  • Third trimester consultation (28–32 weeks’ gestation) with anesthesiology

  • Multidisciplinary care plan formulated, documented, and communicated in patient’s chart by 32 weeks’ gestation

Laboratory Data
  • Preconception or early pregnancy FXI level

  • Third trimester (28–32 weeks’ gestation) FXI level

Intrapartum and Delivery Care
  • Consider delivery at a tertiary care center with specialized care (hematology consult, transfusion capabilities)

  • Consider consultation with hematology and maternal-fetal medicine/perinatology on admission to Labor and Delivery Unit (LDU)

  • Team-based communication to ensure needs for medication, equipment, and personnel are anticipated and met

  • Ongoing assessment of evolving hemorrhage risk and reevaluation of plan with hematology as needed

  • Avoid operative vaginal delivery (forceps or vacuum) and scalp electrode placement

  • Active type and screen in the blood bank

  • Patients with a negative bleeding history (low-to- moderate risk):
    • Prophylactic tranexamic acid administration at the time of delivery (1 g IV) or standard of care treatment
    • Prophylactic oxytocin administration per local standard of care
    • Anticipatory planning with blood bank and/or pharmacy
  • Patients with a positive or unknown bleeding history (high risk):
    • Prophylactic tranexamic acid administration at time of delivery (1 g IV) at time of delivery for all patients if FXI not a consideration
    • Consider prophylactic administration of FXI concentrate (15 U/kg), plasma (15–20 mL/kg) or rFVIIa (15–30 μg/kg)
  • If not given prophylactically, ensure that FXI concentrate, plasma, or rFVIIa is immediately available, if needed.

Anesthesia Care
  • Consider low-risk pain-control options such as IV medications or inhaled nitrous oxide

  • Consider prophylaxis for regional anesthesia placement with tranexamic acid, plasma, FXI concentrate, or rFVIIa based on patient’s risk

Neonatal Care
  • Notify pediatric care team of maternal FXI deficiency

  • Hold pressure for 15 min after intramuscular injections

  • Avoid invasive procedures until hematology evaluation